1. DDIS-13. UNDERSTANDING GLIOBLASTOMA SUSCEPTIBILITY TO TOP2-TARGETING DRUGS FOR PERSONALIZED THERAPY. (5th November 2018) Authors: Awah, Chidiebere; Gonzalez-Buendía, Edgar; Zhao, Junfei; Feldstein, Eric; Chen, Li; Mahajan, Aayushi; Warnke, Louisa; Wang, Lu; Park, Cheol; Winter, Jan; Konermann, Silvana; Shilatifard, Ali; James, C David; Rabadan, Raul; Hsu, Patrick; Bansal, Mukesh; Ahmed, Atique; Sonabend, Adam Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. DRES-02. CILIARY PROTEIN ARL13B PROMOTES CHEMORESISTANCE BY MODULATE GLIOBLASTOMA PURINE BIOSYNTHESIS. (5th November 2018) Authors: Shireman, Jack; Atashi, Fatemeh; Park, Cheol; Warnke, Louisa; Miska, Jason; Ahmed, Atique Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗